UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 41 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $321,000 | +11.8% | 53,429 | -2.5% | 0.00% | – |
Q4 2020 | $287,000 | +61.2% | 54,822 | +6.4% | 0.00% | – |
Q3 2020 | $178,000 | -58.7% | 51,530 | +3.9% | 0.00% | -100.0% |
Q2 2020 | $431,000 | +69.0% | 49,615 | +13.1% | 0.00% | 0.0% |
Q1 2020 | $255,000 | -18.5% | 43,887 | +1.2% | 0.00% | 0.0% |
Q4 2019 | $313,000 | +24.7% | 43,378 | +5.6% | 0.00% | – |
Q3 2019 | $251,000 | -35.6% | 41,091 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $390,000 | +23.4% | 41,091 | +5.5% | 0.00% | 0.0% |
Q1 2019 | $316,000 | -50.1% | 38,954 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $633,000 | +402.4% | 38,954 | +404.3% | 0.00% | – |
Q3 2018 | $126,000 | +8.6% | 7,724 | 0.0% | 0.00% | – |
Q2 2018 | $116,000 | – | 7,724 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
Leap Investments LP | 13,400 | $78,000 | 0.11% |
Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |